Proficio Capital Partners LLC lowered its position in AxoGen, Inc. (NASDAQ:AXGN) by 20.5% during the second quarter, Holdings Channel reports. The institutional investor owned 116,266 shares of the company’s stock after selling 30,000 shares during the period. Proficio Capital Partners LLC’s holdings in AxoGen were worth $781,000 as of its most recent filing with the SEC.

Separately, UBS Group AG increased its stake in shares of AxoGen by 991.7% in the first quarter. UBS Group AG now owns 97,946 shares of the company’s stock worth $525,000 after buying an additional 88,974 shares during the last quarter. Hedge funds and other institutional investors own 57.87% of the company’s stock.

Institutional Ownership by Quarter for AxoGen (NASDAQ:AXGN)

AxoGen, Inc. (NASDAQ:AXGN) traded down 0.23% during midday trading on Monday, hitting $8.70. 74,862 shares of the stock were exchanged. The stock’s market cap is $262.15 million. The firm’s 50-day moving average is $8.74 and its 200 day moving average is $6.99. AxoGen, Inc. has a 52 week low of $4.08 and a 52 week high of $9.88.

AxoGen (NASDAQ:AXGN) last issued its earnings results on Wednesday, August 3rd. The company reported ($0.09) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.12) by $0.03. AxoGen had a negative net margin of 37.90% and a negative return on equity of 193.60%. Equities research analysts expect that AxoGen, Inc. will post ($0.40) EPS for the current fiscal year.

Separately, Wedbush reiterated an “outperform” rating and set a $10.00 price target (up from $9.00) on shares of AxoGen in a research report on Thursday, August 4th.

In related news, Director Joseph M. Mandato sold 149,618 shares of the business’s stock in a transaction dated Tuesday, August 9th. The shares were sold at an average price of $8.54, for a total transaction of $1,277,737.72. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, VP John P. Engels acquired 4,000 shares of the stock in a transaction that occurred on Friday, October 7th. The shares were acquired at an average cost of $7.50 per share, with a total value of $30,000.00. Following the transaction, the vice president now owns 98,425 shares in the company, valued at $738,187.50. The disclosure for this purchase can be found here. Corporate insiders own 9.33% of the company’s stock.

5 Day Chart for NASDAQ:AXGN

Want to see what other hedge funds are holding AXGN? Visit to get the latest 13F filings and insider trades for AxoGen, Inc. (NASDAQ:AXGN).

Receive News & Ratings for AxoGen Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AxoGen Inc. and related companies with's FREE daily email newsletter.